Director Share Dealings - GSK plc (GSK)

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

≈ Figures for the value of trade may not add up due to rounding.

Recent deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈
22 October 2026	Maya Martinez-DavisOther President	Buy Regular purchase transaction	9	$51.21	$460.89
13 October 2026	Maya Martinez-DavisOther President	Buy Regular purchase transaction	352	$46.95	$16,525.77
13 October 2026	Shobie RamakrishnanCTO	Buy Regular purchase transaction	725	$46.95	$34,037.45
13 October 2026	James Robert Anthony FordGeneral Counsel	Buy Regular purchase transaction	326	$46.95	$15,305.11
12 October 2026	Maya Martinez-DavisOther President	Buy Regular purchase transaction	179	$46.54	$8,330.66
9 October 2026	Lynn BaxterOther President	Buy Regular purchase transaction	7	£17.65	£123.58
9 October 2026	David Simon RedfernOther President	Buy Regular purchase transaction	7	£17.65	£123.58
9 October 2026	James Robert Anthony FordGeneral Counsel	Buy Regular purchase transaction	7	£17.65	£123.58
9 October 2026	Lynn BaxterOther President	Buy Regular purchase transaction	7	£17.67	£123.66
9 October 2026	Lynn BaxterOther President	Buy Regular purchase transaction	7	£17.65	£123.58

5 most significant deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
5 February 2026	Hal V. BarronNon-Executive Director	Sell Regular sell transaction (market)	67,602	$59.17	$4,000,010.34	549,094
13 February 2026	Tony WoodChief Level Officer	Sell Tax related	103,330	£21.60	£2,231,948.67	0
5 February 2026	David Simon RedfernOther President	Sell Option/Award related	100,000	£21.09	£2,109,000.00	0
13 February 2026	Shobie RamakrishnanCTO	Sell Tax related	30,806	$58.85	$1,812,960.83	0
13 February 2026	Regis SimardOther President	Sell Tax related	81,449	£21.60	£1,759,314.69	0

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.